227 related articles for article (PubMed ID: 34802210)
1. [Progress of Immune Checkpoint Inhibitors
in the Treatment of Advanced Pulmonary Neuroendocrine Tumors].
Chen H; Meng Q
Zhongguo Fei Ai Za Zhi; 2021 Nov; 24(11):784-789. PubMed ID: 34802210
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis.
Zhang S; Chen J; Zhang R; Xu L; Wang Y; Yuan Z; Hou X; Feng J
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1063-1077. PubMed ID: 35249158
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
Langfort R; Rudziński P; Burakowska B
Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Neuroendocrine Tumors.
Borczuk AC
Surg Pathol Clin; 2020 Mar; 13(1):35-55. PubMed ID: 32005434
[TBL] [Abstract][Full Text] [Related]
5. The immune tumour microenvironment of neuroendocrine tumours and its implications for immune checkpoint inhibitors.
Takkenkamp TJ; Jalving M; Hoogwater FJH; Walenkamp AME
Endocr Relat Cancer; 2020 Sep; 27(9):R329-R343. PubMed ID: 32590336
[TBL] [Abstract][Full Text] [Related]
6. The molecular pathogenesis and management of bronchial carcinoids.
Cakir M; Grossman A
Expert Opin Ther Targets; 2011 Apr; 15(4):457-91. PubMed ID: 21275849
[TBL] [Abstract][Full Text] [Related]
7. International trends in pulmonary neuroendocrine cancer studies:a scientometric study.
Tanaka H; Del Giglio A
Einstein (Sao Paulo); 2022; 20():eRW0113. PubMed ID: 36287436
[TBL] [Abstract][Full Text] [Related]
8. [Symptoms and diagnostics of lung neuroendocrine tumors].
Tamási L; Müller V
Orv Hetil; 2011 Mar; 152(10):366-70. PubMed ID: 21354952
[TBL] [Abstract][Full Text] [Related]
9. PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids.
Lococo F; Cesario A; Paci M; Filice A; Versari A; Rapicetta C; Ricchetti T; Sgarbi G; Alifano M; Cavazza A; Treglia G
Tumour Biol; 2014 Sep; 35(9):8369-77. PubMed ID: 24850179
[TBL] [Abstract][Full Text] [Related]
10. Gastroenteropancreatic neuroendocrine tumors: update on therapeutics.
Ganetsky A; Bhatt V
Ann Pharmacother; 2012 Jun; 46(6):851-62. PubMed ID: 22589450
[TBL] [Abstract][Full Text] [Related]
11. Differential Diagnosis in Neuroendocrine Neoplasms of the Larynx.
Hunt JL; Ferlito A; Hellquist H; Rinaldo A; Skálová A; Slootweg PJ; Willems SM; Cardesa A
Adv Anat Pathol; 2017 May; 24(3):161-168. PubMed ID: 28338500
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and treatment of the neuroendocrine tumors of the lung].
Gálffy G
Magy Onkol; 2018 Jul; 62(2):113-118. PubMed ID: 30027939
[TBL] [Abstract][Full Text] [Related]
13. Combined carcinoid tumor and squamous cell carcinoma of lung: expanding the spectrum of combined tumors of lung.
Owens CL; Fraire AE
Int J Surg Pathol; 2011 Apr; 19(2):273-5. PubMed ID: 21427100
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in Neuroendocrine Neoplasms: Where Are We Now?
Fazio N; Abdel-Rahman O
Curr Treat Options Oncol; 2021 Feb; 22(3):19. PubMed ID: 33559013
[TBL] [Abstract][Full Text] [Related]
15. Distribution and Characteristics of Pulmonary Neuroendocrine Tumors: Single Institution Experience in Lebanon.
Kesrouani C; Ghorra C; Rassy M; Kourie HR; Kattan J
Asian Pac J Cancer Prev; 2016; 17(5):2579-81. PubMed ID: 27268633
[TBL] [Abstract][Full Text] [Related]
16. Functional imaging evaluation in the detection, diagnosis, and histologic differentiation of pulmonary neuroendocrine tumors.
Lococo F; Treglia G; Cesario A; Paci M; Filice A; Versari A; Filosso PL
Thorac Surg Clin; 2014 Aug; 24(3):285-92. PubMed ID: 25065929
[TBL] [Abstract][Full Text] [Related]
17. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].
Schnabel PA; Junker K
Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary carcinoid and related tumours.
Hasleton PS; Bostanci G
Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE
Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
